What is the recommended dosing regimen of polymyxin B/trimethoprim ophthalmic solution for patients aged two months and older?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Polymyxin B/Trimethoprim Ophthalmic Solution Dosing

For patients aged 2 months and older with mild to moderate bacterial conjunctivitis, instill 1 drop in the affected eye(s) every 3 hours (maximum 6 doses per day) for 7-10 days. 1

Dosing Regimen Details

The FDA-approved dosing for polymyxin B/trimethoprim ophthalmic solution is straightforward and age-independent for patients meeting the minimum age requirement:

  • Frequency: Every 3 hours while awake
  • Maximum daily doses: 6 drops per day
  • Duration: 7-10 days
  • Minimum age: 2 months 1

Critical Safety Considerations

This medication is contraindicated in infants younger than 2 months of age. 1 Safety and effectiveness have not been established in this age group, and the trimethoprim component carries a theoretical risk of kernicterus in very young infants due to potential interference with bilirubin metabolism.

Clinical Context and Alternatives

While the FDA label provides clear dosing guidance 1, recent comparative effectiveness data suggests important clinical considerations:

  • Efficacy: Polymyxin B/trimethoprim remains clinically effective with cure rates of 96% by day 7-10, comparable to newer fluoroquinolones like moxifloxacin 2
  • Speed of response: Moxifloxacin demonstrates faster symptom resolution (81% cure at 48 hours vs 44% with polymyxin B/trimethoprim) 3, though ultimate cure rates are equivalent
  • Cost-effectiveness: Polymyxin B/trimethoprim offers significant cost savings compared to fluoroquinolones while maintaining comparable efficacy 2

Pregnancy and Lactation

This combination is Pregnancy Category C. Trimethoprim has shown teratogenic effects in animal studies at high doses, though limited human data from 186 pregnancies showed no increased risk of congenital abnormalities. Use only if potential benefits justify potential fetal risks. 1

Excretion in human breast milk is unknown; exercise caution when prescribing to nursing mothers. 1

Common Pitfalls to Avoid

  • Do not use in children under 2 months - this is an absolute contraindication
  • Ensure proper dosing frequency - every 3 hours means approximately 6 times daily while awake, not every 3 hours around the clock
  • Complete the full course - even if symptoms improve earlier, complete 7-10 days to ensure bacterial eradication
  • Monitor for hypersensitivity - discontinue if allergic reactions to trimethoprim or polymyxin B occur

References

Related Questions

What is the appropriate dose of polymyxin B ophthalmic solution eye drops for a 4-year-old child?
What is the appropriate dosage, indications, contraindications, and follow‑up for Polymyxin B ophthalmic solution?
What are the pharmacokinetic properties of Polymyxin B, including its route of administration, distribution volume, protein binding, metabolism, clearance, half‑life, and dosing adjustments in renal impairment?
What is the appropriate dosing schedule for a 1 mg/mL polymyxin B/trimethoprim ophthalmic solution?
What is the recommended dosing regimen of Polytrim (polymyxin B 0.1 mg/mL + trimethoprim 1 mg/mL) for a 17‑year‑old female?
How should a patient with sinus rhythm and borderline first-degree atrioventricular (AV) block be managed?
Is Shingrix vaccination recommended for a healthy 22‑year‑old without immunocompromising conditions?
What are the guidelines for measles, mumps, and rubella (MMR) booster vaccination in a 40-year-old female?
How should a 46-year-old male with left anterior descending coronary artery disease and low-voltage precordial leads who is asymptomatic be evaluated and managed?
What are the indications, recommended dosing regimens, contraindications, and alternative therapies for macrolide antibiotics?
Can a patient with Sjögren’s syndrome safely take an antihistamine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.